Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium, Vascular | 7 | 2010 | 28 | 1.320 |
Why?
|
| Endothelial Cells | 8 | 2014 | 42 | 1.270 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 6 | 2008 | 32 | 0.830 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2007 | 28 | 0.800 |
Why?
|
| Lysophosphatidylcholines | 4 | 2007 | 8 | 0.780 |
Why?
|
| rhoA GTP-Binding Protein | 3 | 2008 | 5 | 0.760 |
Why?
|
| Catenins | 2 | 2011 | 3 | 0.720 |
Why?
|
| Signal Transduction | 8 | 2014 | 417 | 0.710 |
Why?
|
| Capillary Permeability | 4 | 2006 | 17 | 0.600 |
Why?
|
| Up-Regulation | 2 | 2012 | 166 | 0.430 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2004 | 51 | 0.410 |
Why?
|
| Cells, Cultured | 10 | 2010 | 505 | 0.380 |
Why?
|
| Transcription Factors | 2 | 2010 | 170 | 0.330 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2008 | 1 | 0.310 |
Why?
|
| Carrier Proteins | 3 | 2004 | 103 | 0.290 |
Why?
|
| Receptors, Lysophospholipid | 1 | 2007 | 2 | 0.280 |
Why?
|
| Monocytes | 1 | 2007 | 60 | 0.270 |
Why?
|
| Thrombin | 4 | 2014 | 15 | 0.260 |
Why?
|
| Cyclic AMP | 5 | 2008 | 32 | 0.250 |
Why?
|
| Protein Kinase C | 1 | 2005 | 48 | 0.240 |
Why?
|
| Animals | 10 | 2010 | 3551 | 0.240 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 269 | 0.240 |
Why?
|
| Brain | 4 | 2011 | 1603 | 0.230 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 16 | 0.210 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 44 | 0.210 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 37 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 180 | 0.200 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 70 | 0.200 |
Why?
|
| Isoenzymes | 1 | 2002 | 50 | 0.190 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 105 | 0.170 |
Why?
|
| Humans | 14 | 2014 | 26260 | 0.160 |
Why?
|
| Skin | 3 | 2005 | 99 | 0.160 |
Why?
|
| Cattle | 3 | 2010 | 120 | 0.160 |
Why?
|
| Pulmonary Artery | 3 | 2011 | 31 | 0.160 |
Why?
|
| Phosphorylation | 5 | 2012 | 134 | 0.140 |
Why?
|
| COS Cells | 2 | 2008 | 33 | 0.140 |
Why?
|
| Inflammation | 2 | 2011 | 264 | 0.140 |
Why?
|
| Mutation | 2 | 2008 | 324 | 0.130 |
Why?
|
| Gene Expression | 3 | 2006 | 196 | 0.120 |
Why?
|
| Retina | 1 | 2014 | 7 | 0.120 |
Why?
|
| Serine | 3 | 2012 | 11 | 0.120 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 5 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 93 | 0.110 |
Why?
|
| Dermis | 2 | 2006 | 9 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2012 | 8 | 0.110 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2005 | 10 | 0.110 |
Why?
|
| Electric Impedance | 2 | 2005 | 25 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2012 | 39 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2014 | 114 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2014 | 52 | 0.110 |
Why?
|
| Cell Line | 2 | 2011 | 262 | 0.100 |
Why?
|
| Genistein | 1 | 2012 | 3 | 0.100 |
Why?
|
| Phytoestrogens | 1 | 2012 | 4 | 0.100 |
Why?
|
| Aorta | 1 | 2012 | 14 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2003 | 290 | 0.090 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 12 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2011 | 23 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 114 | 0.090 |
Why?
|
| Neutrophils | 1 | 2011 | 89 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2010 | 23 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 37 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2010 | 37 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2007 | 107 | 0.080 |
Why?
|
| Adenoviridae | 3 | 2004 | 17 | 0.080 |
Why?
|
| Hemostatics | 2 | 2014 | 12 | 0.080 |
Why?
|
| Models, Biological | 1 | 2011 | 292 | 0.080 |
Why?
|
| Serum Response Element | 1 | 2008 | 1 | 0.080 |
Why?
|
| rho-Specific Guanine Nucleotide Dissociation Inhibitors | 1 | 2008 | 1 | 0.080 |
Why?
|
| Consensus Sequence | 1 | 2008 | 2 | 0.080 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 17 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 30 | 0.080 |
Why?
|
| Transfection | 1 | 2008 | 111 | 0.080 |
Why?
|
| Protein Binding | 1 | 2008 | 118 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2005 | 105 | 0.070 |
Why?
|
| Cell Survival | 2 | 2005 | 114 | 0.070 |
Why?
|
| Myosin Light Chains | 1 | 2007 | 2 | 0.070 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2007 | 4 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 6 | 0.070 |
Why?
|
| Retroviridae | 1 | 2007 | 5 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2007 | 21 | 0.070 |
Why?
|
| Mutagenesis | 1 | 2006 | 12 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2006 | 56 | 0.060 |
Why?
|
| Guanosine Triphosphate | 1 | 2005 | 4 | 0.060 |
Why?
|
| Protein Kinase C-alpha | 1 | 2005 | 7 | 0.060 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2005 | 4 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2004 | 63 | 0.060 |
Why?
|
| Sphingosine | 1 | 2005 | 2 | 0.060 |
Why?
|
| Phosphorylcholine | 1 | 2005 | 5 | 0.060 |
Why?
|
| Rabbits | 2 | 2004 | 181 | 0.060 |
Why?
|
| Protein Transport | 1 | 2005 | 30 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2005 | 17 | 0.060 |
Why?
|
| Colforsin | 1 | 2004 | 12 | 0.060 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2004 | 5 | 0.060 |
Why?
|
| Rolipram | 1 | 2004 | 3 | 0.060 |
Why?
|
| Isoquinolines | 1 | 2004 | 11 | 0.060 |
Why?
|
| Adenosine Monophosphate | 1 | 2004 | 6 | 0.060 |
Why?
|
| Lung | 1 | 2005 | 148 | 0.060 |
Why?
|
| Albuterol | 1 | 2004 | 15 | 0.060 |
Why?
|
| Sulfonamides | 1 | 2004 | 40 | 0.060 |
Why?
|
| Ion Channels | 1 | 2004 | 145 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 89 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2004 | 76 | 0.050 |
Why?
|
| Microcirculation | 1 | 2003 | 28 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2003 | 34 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 134 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 44 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 262 | 0.050 |
Why?
|
| Vascular Resistance | 1 | 2002 | 13 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 33 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 386 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 32 | 0.030 |
Why?
|
| Rats | 2 | 2007 | 634 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2005 | 59 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2012 | 40 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 62 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2007 | 2 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2007 | 7 | 0.020 |
Why?
|
| p21-Activated Kinases | 1 | 2007 | 8 | 0.020 |
Why?
|
| Swine | 1 | 2007 | 70 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2005 | 2 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2005 | 3 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2005 | 8 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2005 | 15 | 0.020 |
Why?
|
| Lysophospholipids | 1 | 2005 | 3 | 0.020 |
Why?
|
| Cell Division | 1 | 2005 | 80 | 0.020 |
Why?
|
| Antibodies | 1 | 2005 | 46 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 38 | 0.010 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2004 | 1 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2004 | 5 | 0.010 |
Why?
|
| Sarcolemma | 1 | 2004 | 4 | 0.010 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2004 | 4 | 0.010 |
Why?
|
| Diterpenes | 1 | 2004 | 3 | 0.010 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2004 | 6 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2004 | 13 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2005 | 71 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 76 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 86 | 0.010 |
Why?
|
| Feedback | 1 | 2004 | 28 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 158 | 0.010 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2004 | 1 | 0.010 |
Why?
|
| Tritium | 1 | 2004 | 7 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 204 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2004 | 17 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2004 | 14 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2004 | 36 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 18 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 29 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2002 | 2 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 8 | 0.010 |
Why?
|
| Lymphokines | 1 | 2002 | 5 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 5 | 0.010 |
Why?
|
| Threonine | 1 | 2002 | 8 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2002 | 7 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 33 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2002 | 40 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2002 | 52 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2002 | 158 | 0.010 |
Why?
|